nor did mr copulos or mr ralph.
the announcement stated further that the medivac board had elected mr ralph as its executive chairman, with mr radojev, mr mcpherson and mr copulos being non-executive directors.
mr copulos subsequently invested in diakyne through a company which mr copulos controlled.